Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/8716 |
Resumo: | GarnerlaIcahn School of Medicine at Mount Sinai. New York, NY |
id |
CRUZ_ea106b86529d739a416a24c73e7ea3d2 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/8716 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Goldstone, StephenJessen, HeikoPalefsky, Joel MGiuliano, Anna RMoreira Júnior, Edson DuarteVardas, EftyhiaAranda, CarlosHillman, Richard JFerris, Daron GCoutlee, FrancoisMarshall, J. BrookeVuocolo, ScottHaupt, Richard MGuris, DalyaGarner, Elizabeth I. O2014-11-04T18:49:21Z2014-11-04T18:49:21Z2013GOLDSTONE, S. E. et al. Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine, v. 31, n. 37, p. 3849-3855, 2013.1873-2518https://www.arca.fiocruz.br/handle/icict/8716dx.doi.org/10.1016/j.vaccine.2013.06.057engElsevier LtdQuadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males.info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleGarnerlaIcahn School of Medicine at Mount Sinai. New York, NYJ2: Private Clinic for Infectious Diseases. Berlin, GermanyUniversity of California San Francisco. Department of Medicine. San Francisco, CA, USARisk Assessment, Detection, and Intervention Program. H. Lee Moffitt Cancer Center and Research Institute. Tampa, FL, USAAssociação Obras Sociais Irmã Dulce. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Salvador, BA, BrasilUniversity of Stellenbosch. Division of Medical Virology. Tygerberg, South Africa / Lancet Laboratories. Johannesburg, South AfricahUniversity Medical Center. National Public Health Institute. Morelos, MexicoWestern Sydney Sexual Health Center. Sydney, AustraliaGynecologic Cancer Prevention Center. Georgia Health Sciences University. Augusta, GA, USAUniversité de Montréal. Centre de Recherche du CHUM. Montréal, Quebec, CanadaMerck & Co. North Wales, PA, USAMerck & Co. North Wales, PA, USAMerck & Co. North Wales, PA, USAA small number of HPV types are related to a majority of HPV-related neoplastic lesions in humans. High-risk types such as HPV 16 and 18 are most often implicated, although other oncogenic and non-oncogenic HPV types can cause disease in men. The efficacy of the quadrivalent HPV vaccine (qHPV) against external genital lesions and intra-anal disease related to HPV in men has been demonstrated. This report examines the vaccine's efficacy against disease due to 10 additional non-vaccine HPV types, as well as efficacy regardless of HPV detection. The data presented suggest that vaccinating males against HPV 6, 11, 16 and 18 protects them against most vaccine HPV-type related anogenital disease. However, significant efficacy against disease due to non-vaccine HPV types was not seen. In addition, the data do not provide any evidence that vaccination with qHPV vaccine will increase the likelihood of disease caused by non-vaccine types in the short termHPVYoungMalesMen who have sex with menaNeoplasias do Ânus/virologiaInfecções por Papillomavirus/prevenção & controleInfecções por Papillomavirus/virologiaVacinas contra Papillomavirus/uso terapêuticoAdolescenteAdultoCanal Anal/patologiaNeoplasias do Ânus/epidemiologiaNeoplasias dos Genitais Masculinos/patologiaPapillomavirus Humano 11/patogenicidadePapillomavirus Humano 16/patogenicidadeHumanosMasculinoInfecções por Papillomavirus/epidemiologiaResultado do TratamentoAdulto Joveminfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-81914https://www.arca.fiocruz.br/bitstream/icict/8716/1/license.txt7d48279ffeed55da8dfe2f8e81f3b81fMD51ORIGINALGoldstone SE Quadrivalent....pdfGoldstone SE Quadrivalent....pdfapplication/pdf688410https://www.arca.fiocruz.br/bitstream/icict/8716/2/Goldstone%20SE%20Quadrivalent....pdf4e46a6ef9c00eb3d518afe5dc8974e71MD52TEXTGoldstone SE Quadrivalent....pdf.txtGoldstone SE Quadrivalent....pdf.txtExtracted texttext/plain37933https://www.arca.fiocruz.br/bitstream/icict/8716/3/Goldstone%20SE%20Quadrivalent....pdf.txt79675928b517665991be121a398f5f81MD53icict/87162023-03-15 14:33:15.28oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:33:15Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. |
title |
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. |
spellingShingle |
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Goldstone, Stephen HPV Young Males Men who have sex with mena Neoplasias do Ânus/virologia Infecções por Papillomavirus/prevenção & controle Infecções por Papillomavirus/virologia Vacinas contra Papillomavirus/uso terapêutico Adolescente Adulto Canal Anal/patologia Neoplasias do Ânus/epidemiologia Neoplasias dos Genitais Masculinos/patologia Papillomavirus Humano 11/patogenicidade Papillomavirus Humano 16/patogenicidade Humanos Masculino Infecções por Papillomavirus/epidemiologia Resultado do Tratamento Adulto Jovem |
title_short |
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. |
title_full |
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. |
title_fullStr |
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. |
title_full_unstemmed |
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. |
title_sort |
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. |
author |
Goldstone, Stephen |
author_facet |
Goldstone, Stephen Jessen, Heiko Palefsky, Joel M Giuliano, Anna R Moreira Júnior, Edson Duarte Vardas, Eftyhia Aranda, Carlos Hillman, Richard J Ferris, Daron G Coutlee, Francois Marshall, J. Brooke Vuocolo, Scott Haupt, Richard M Guris, Dalya Garner, Elizabeth I. O |
author_role |
author |
author2 |
Jessen, Heiko Palefsky, Joel M Giuliano, Anna R Moreira Júnior, Edson Duarte Vardas, Eftyhia Aranda, Carlos Hillman, Richard J Ferris, Daron G Coutlee, Francois Marshall, J. Brooke Vuocolo, Scott Haupt, Richard M Guris, Dalya Garner, Elizabeth I. O |
author2_role |
author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Goldstone, Stephen Jessen, Heiko Palefsky, Joel M Giuliano, Anna R Moreira Júnior, Edson Duarte Vardas, Eftyhia Aranda, Carlos Hillman, Richard J Ferris, Daron G Coutlee, Francois Marshall, J. Brooke Vuocolo, Scott Haupt, Richard M Guris, Dalya Garner, Elizabeth I. O |
dc.subject.en.pt_BR.fl_str_mv |
HPV Young Males Men who have sex with mena |
topic |
HPV Young Males Men who have sex with mena Neoplasias do Ânus/virologia Infecções por Papillomavirus/prevenção & controle Infecções por Papillomavirus/virologia Vacinas contra Papillomavirus/uso terapêutico Adolescente Adulto Canal Anal/patologia Neoplasias do Ânus/epidemiologia Neoplasias dos Genitais Masculinos/patologia Papillomavirus Humano 11/patogenicidade Papillomavirus Humano 16/patogenicidade Humanos Masculino Infecções por Papillomavirus/epidemiologia Resultado do Tratamento Adulto Jovem |
dc.subject.decs.pt_BR.fl_str_mv |
Neoplasias do Ânus/virologia Infecções por Papillomavirus/prevenção & controle Infecções por Papillomavirus/virologia Vacinas contra Papillomavirus/uso terapêutico Adolescente Adulto Canal Anal/patologia Neoplasias do Ânus/epidemiologia Neoplasias dos Genitais Masculinos/patologia Papillomavirus Humano 11/patogenicidade Papillomavirus Humano 16/patogenicidade Humanos Masculino Infecções por Papillomavirus/epidemiologia Resultado do Tratamento Adulto Jovem |
description |
GarnerlaIcahn School of Medicine at Mount Sinai. New York, NY |
publishDate |
2013 |
dc.date.issued.fl_str_mv |
2013 |
dc.date.accessioned.fl_str_mv |
2014-11-04T18:49:21Z |
dc.date.available.fl_str_mv |
2014-11-04T18:49:21Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
GOLDSTONE, S. E. et al. Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine, v. 31, n. 37, p. 3849-3855, 2013. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/8716 |
dc.identifier.issn.none.fl_str_mv |
1873-2518 |
dc.identifier.doi.none.fl_str_mv |
dx.doi.org/10.1016/j.vaccine.2013.06.057 |
identifier_str_mv |
GOLDSTONE, S. E. et al. Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine, v. 31, n. 37, p. 3849-3855, 2013. 1873-2518 dx.doi.org/10.1016/j.vaccine.2013.06.057 |
url |
https://www.arca.fiocruz.br/handle/icict/8716 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Elsevier Ltd |
publisher.none.fl_str_mv |
Elsevier Ltd |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/8716/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/8716/2/Goldstone%20SE%20Quadrivalent....pdf https://www.arca.fiocruz.br/bitstream/icict/8716/3/Goldstone%20SE%20Quadrivalent....pdf.txt |
bitstream.checksum.fl_str_mv |
7d48279ffeed55da8dfe2f8e81f3b81f 4e46a6ef9c00eb3d518afe5dc8974e71 79675928b517665991be121a398f5f81 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009141161000960 |